Baseline mean platelet volume is a strong predictor of major and life-threatening bleedings after transcatheter aortic valve replacement
Open Access
- 30 November 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (11), e0260439
- https://doi.org/10.1371/journal.pone.0260439
Abstract
Bleeding following transcatheter aortic valve replacement (TAVR) has important prognostic implications. This study sought to evaluate the impact of baseline mean platelet volume (MPV) on bleeding events after TAVR. Patients undergoing TAVR between February 2010 and May 2019 were included. Low MPV (L-MPV) was defined as MPV ≤10 fL and high MPV (H-MPV) as MPV >10 fL. The primary endpoint was the occurrence of major/life-threatening bleeding complications (MLBCs) at one-year follow-up. Among 1,111 patients, 398 (35.8%) had L-MPV and 713 (64.2%) had H-MPV. The rate of MLBCs at 1 year was higher in L-MPV patients compared with H-MPV patients (22.9% vs. 17.7% respectively, p = 0.034). L-MPV was associated with vascular access-site complications (36.2% vs. 28.9%, p = 0.012), early (<30 days) major bleeding (15.6% vs. 9.4%, p2 units (23.9% vs. 17.5%, p = 0.01). No impact of baseline MPV on overall death, cardiovascular death and ischemic events (myocardial infarction and stroke) was evidenced. Multivariate analysis using Fine and Gray model identified preprocedural hemoglobin (sHR 0.84, 95%CI [0.75–0.93], p = 0.001), preprocedural L-MPV (sHR 1.64, 95%CI [1.16–2.32], p = 0.005) and closure time adenosine diphosphate post-TAVR (sHR 2.71, 95%CI [1.87–3.95], p<0.001) as predictors of MLBCs. Preprocedural MPV was identified as an independent predictor of MLBCs one year after TAVR, regardless of the extent of platelet inhibition and primary hemostasis disorders.This publication has 38 references indexed in Scilit:
- Incidence, predictors and prognostic value of serious hemorrhagic complications following transcatheter aortic valve implantationInternational Journal of Cardiology, 2013
- Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysisJournal of Thrombosis and Haemostasis, 2009
- Role of Reticulated Platelets and Platelet Size Heterogeneity on Platelet Activity After Dual Antiplatelet Therapy With Aspirin and Clopidogrel in Patients With Stable Coronary Artery DiseaseJournal of Invasive Cardiology, 2008
- Platelets and heart failureEuropean Heart Journal, 2006
- The mean platelet volume in patients with obesityInternational Journal of Clinical Practice, 2005
- Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapyAnnals of Medicine, 2004
- Altered megakaryocyte–platelet haemostatic axis in hypercholesterolaemiaPlatelets, 2001
- Platelet glycoprotein IIb‐IIIa and size are increased in acute myocardial infarctionEuropean Journal of Clinical Investigation, 1994
- Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosisClinical and Laboratory Haematology, 1992
- Influence of platelet size on outcome after myocardial infarctionThe Lancet, 1991